VBI
is a Massachusetts-based biopharmaceutical company that researches and develops immunotherapeutic candidates for the treatment of cancer and infectious diseases... Read moreVBI
is a Massachusetts-based biopharmaceutical company that researches and develops immunotherapeutic candidates for the treatment of cancer and infectious diseases... Read more
2001
PublicAcquired by SciVac Therapeutics, Inc.NASDAQVBIV
News
Jan 04, 2025
Cision Canada
Press Release: VBI : VBI Vaccines Announces Completion of Sales Process to K2
Jan 02, 2025
Pharmaceutical Business Review
VBI: Brii Biosciences acquires BRII-179 assets from VBI Vaccines
Nov 15, 2024
StreetInsider
Press Release: VBI : VBI Vaccines Issues Voluntary Nationwide Recall of all PreHevbrio Vaccine Due to Discontinuation of Company Operations
Aug 03, 2024
Seeking Alpha
VBI: VBI Vaccines provides restructuring proceedings update
Jul 31, 2024
Medthority
VBI: VBI Vaccines files for bankruptcy
May 29, 2024
MarketScreener
VBI: VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients
May 22, 2024
MarketScreener
VBI: VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients
May 16, 2024
Owler
VBI Vaccines, Inc.: VBI's revenue changed from $8.68M in Dec 2023 to $9.41M in Mar 2024
May 15, 2024
Business Wire
Press Release: VBI : VBI Vaccines Reports First Quarter 2024 Financial Results
May 13, 2024
PLANT
VBI: VBI Vaccines expands partnership with Canadian government on a vaccine platform
VBI Competitors
1
2
3
4
5
6
7
8
9
10